Health services investors and dealmakers entered 2026 with strong momentum, but geopolitical dynamics, policy, reimbursement uncertainty, and ongoing pressure from the “SaaS apocalypse” tempered deal volume. Even so, total deal value remained resilient, signaling a market that is not retreating but repricing risk and rewarding execution. In this environment, strategic acquirers and private equity sponsors are prioritizing scalable, cash-generating platforms with clear reimbursement visibility, while using bolt-ons and carve-outs to sharpen portfolio focus and accelerate value creation.
Read the full article: PwC: Health Services – US Deals 2026 Midyear Outlook //
Source: https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html